RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS
RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS
Awtorizzat
- Cephalexin benzathine
Identifikazzjoni tal-prodott
Isem tal-mediċina:
RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS
Rilexine DC, 375 mg, intramaminė suspensija užtrūkusioms karvėms
Sustanza attiva:
- Disponibbli biss fi English
Metodu ta’ amministrazzjoni:
-
Użu intramammarju
Dettalji tal-prodott
Sustanza attiva / Qawwa:
-
Disponibbli biss fi English500.00milligram(s)1.00Syringe
Forma farmaċewtika:
-
Suspensjoni intramammarja
Withdrawal period by route of administration:
-
Użu intramammarju
- Cattle (cow)
-
Meat and offal4dayMeat and offal: 4 days
-
Milk43day42.5 days after treatment when dry period is 42 days or less
-
Milk12hour12 hours after calving when dry period is more than 42 days
-
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
- QJ51DB01
Status tal-awtorizzazzjoni:
-
Valid
Tagħrif addizzjonali
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
- Virbac
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
- Haupt Pharma Latina S.r.l.
- Virbac
Awtorità responsabbli:
- State Food And Veterinary Service
Numru tal-awtorizzazzjoni:
- LT/2/22/2703/001-003
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
- FR/V/0438/001
Stati Membri Kkonċernati:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Dokumenti
RV2703.pdf
Lithuanian (PDF)
Niżżel Ippubblikat fuq: 26/05/2022
Kemm kienet utli din il-paġna?: